InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
0.00%
)
US TECH 100
19,678.00
(
0.00%
)
Dow Jones
39,753.75
(
0.00%
)
Brent Oil
85.36
(
0.29%
)
Bitcoin
57,147.27
(
-0.35%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

iwfal

Send PM Follow Ignore
Followers 75
Posts 4700
Boards Moderated 0
Alias Born 09/06/2003

iwfal

Member Level

Re: DewDiligence post# 40311

Friday, 01/05/2007 12:18:20 PM

Friday, January 05, 2007 12:18:20 PM

Post# of 252581
Its partner AtheroGenics Inc <AGIX> hopes to present results from a pivotal Phase III clinical trial to the American College of Cardiology (ACC) meeting in New Orleans in March and analysts noted the deadline for research submissions was Jan. 4.

Most (all?) conferences allow you to submit a placeholder if you think you will have news before the event. So I don't think the above logic holds. FWIW.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up